Rtw Investments as of March 31, 2024
Portfolio Holdings for Rtw Investments
Rtw Investments holds 69 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 7.0 | $477M | 18M | 26.94 | |
| Immunocore Hldgs Ads (IMCR) | 5.8 | $391M | 6.0M | 65.00 | |
| Axsome Therapeutics (AXSM) | 5.3 | $359M | 4.5M | 79.80 | |
| Ultragenyx Pharmaceutical (RARE) | 4.9 | $331M | 7.1M | 46.69 | |
| Bruker Corporation (BRKR) | 4.6 | $314M | 3.3M | 93.94 | |
| Argenx Se Sponsored Adr (ARGX) | 3.9 | $263M | 667k | 393.72 | |
| ACADIA Pharmaceuticals (ACAD) | 3.8 | $256M | 14M | 18.49 | |
| Natera (NTRA) | 3.5 | $237M | 2.6M | 91.46 | |
| Ptc Therapeutics I (PTCT) | 3.2 | $216M | 7.4M | 29.09 | |
| Masimo Corporation (MASI) | 3.2 | $215M | 1.5M | 146.85 | |
| Avidity Biosciences Ord (RNA) | 3.0 | $203M | 8.0M | 25.52 | |
| Merus N V (MRUS) | 2.7 | $185M | 4.1M | 45.03 | |
| Cytokinetics Com New (CYTK) | 2.6 | $177M | 2.5M | 70.11 | |
| Apogee Therapeutics (APGE) | 2.4 | $164M | 2.5M | 66.45 | |
| Alkermes SHS (ALKS) | 2.4 | $164M | 6.1M | 27.07 | |
| Protagonist Therapeutics (PTGX) | 2.3 | $154M | 5.3M | 28.93 | |
| Penumbra (PEN) | 2.2 | $151M | 676k | 223.18 | |
| Avadel Pharmaceuticals Sponsored Adr | 2.2 | $149M | 8.8M | 16.89 | |
| Akero Therapeutics (AKRO) | 2.0 | $137M | 5.4M | 25.26 | |
| Establishment Labs Holdings Ord (ESTA) | 2.0 | $136M | 2.7M | 50.90 | |
| Arvinas Ord (ARVN) | 2.0 | $136M | 3.3M | 41.28 | |
| Tarsus Pharmaceuticals (TARS) | 1.8 | $119M | 3.3M | 36.35 | |
| Stryker Corporation (SYK) | 1.7 | $115M | 321k | 357.87 | |
| Madrigal Pharmaceuticals (MDGL) | 1.6 | $106M | 397k | 267.04 | |
| Immatics SHS (IMTX) | 1.6 | $105M | 10M | 10.51 | |
| Sage Therapeutics (SAGE) | 1.5 | $103M | 5.5M | 18.74 | |
| Shockwave Med | 1.4 | $94M | 289k | 325.63 | |
| Dyne Therapeutics (DYN) | 1.3 | $88M | 3.1M | 28.39 | |
| 89bio (ETNB) | 1.3 | $86M | 7.4M | 11.64 | |
| Spyre Therapeutics Com New (SYRE) | 1.3 | $85M | 2.2M | 37.93 | |
| Vericel (VCEL) | 1.2 | $84M | 1.6M | 52.02 | |
| Cargo Therapeutics (CRGX) | 1.2 | $83M | 3.7M | 22.32 | |
| RadNet (RDNT) | 1.2 | $83M | 1.7M | 48.66 | |
| Thermo Fisher Scientific (TMO) | 0.9 | $64M | 111k | 581.21 | |
| 10x Genomics Cl A Com (TXG) | 0.9 | $58M | 1.6M | 37.53 | |
| Stoke Therapeutics (STOK) | 0.8 | $57M | 4.2M | 13.50 | |
| Fulcrum Therapeutics (FULC) | 0.8 | $55M | 5.8M | 9.44 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.8 | $53M | 19M | 2.87 | |
| Insmed Com Par $.01 (INSM) | 0.7 | $51M | 1.9M | 27.13 | |
| Urogen Pharma (URGN) | 0.7 | $49M | 3.3M | 15.00 | |
| Kyverna Therapeutics (KYTX) | 0.7 | $46M | 1.9M | 24.84 | |
| Intuitive Surgical Com New (ISRG) | 0.6 | $40M | 99k | 399.09 | |
| Neurogene (NGNE) | 0.6 | $39M | 769k | 50.90 | |
| Janux Therapeutics (JANX) | 0.6 | $38M | 1.0M | 37.65 | |
| Gh Research Ordinary Shares (GHRS) | 0.5 | $36M | 3.3M | 10.66 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.4 | $30M | 5.6M | 5.27 | |
| Dianthus Therapeutics (DNTH) | 0.3 | $20M | 667k | 30.00 | |
| Essa Pharma Com New (EPIX) | 0.3 | $20M | 2.3M | 8.49 | |
| Lenz Therapeutics (LENZ) | 0.3 | $19M | 863k | 22.33 | |
| Cg Oncology (CGON) | 0.3 | $18M | 414k | 43.90 | |
| Tourmaline Bio (TRML) | 0.3 | $17M | 742k | 22.90 | |
| Roivant Sciences SHS (ROIV) | 0.2 | $15M | 1.5M | 10.54 | |
| Miragen Therapeutics (VRDN) | 0.2 | $11M | 606k | 17.51 | |
| Adicet Bio (ACET) | 0.1 | $9.7M | 4.1M | 2.35 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $7.4M | 350k | 21.07 | |
| Acelyrin | 0.1 | $6.6M | 978k | 6.75 | |
| EXACT Sciences Corporation (EXAS) | 0.1 | $6.6M | 95k | 69.06 | |
| Allurion Technologies Com Shs | 0.1 | $6.1M | 3.5M | 1.75 | |
| Immunic (IMUX) | 0.1 | $6.0M | 4.6M | 1.32 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $5.8M | 3.3M | 1.79 | |
| Glaukos (GKOS) | 0.1 | $5.5M | 59k | 94.29 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $5.4M | 999k | 5.42 | |
| Larimar Therapeutics (LRMR) | 0.1 | $4.9M | 650k | 7.59 | |
| Sab Biotherapeutics Com New (SABS) | 0.1 | $4.2M | 918k | 4.54 | |
| Exagen (XGN) | 0.0 | $2.4M | 1.5M | 1.59 | |
| Beyond Air | 0.0 | $2.1M | 1.2M | 1.74 | |
| Cutera | 0.0 | $2.0M | 1.3M | 1.47 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.4M | 128k | 11.23 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $105k | 350k | 0.30 |